Top compounds associated with response to RP13-512J5.1

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	navitoclax:pluripotin (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.13	0.0003
mRNA	Cytarabine	CTRPv2	pan-cancer	AAC	-0.1	0.0004
mRNA	Crizotinib	CTRPv2	pan-cancer	AAC	-0.11	0.0004
mRNA	barasertib	CTRPv2	pan-cancer	AAC	-0.11	0.0005
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.11	0.0006
mRNA	UNC0638:navitoclax (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.12	0.0007
mRNA	bendamustine	CTRPv2	pan-cancer	AAC	-0.13	0.0009
mRNA	selumetinib:navitoclax (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.12	0.0009
mRNA	selumetinib:JQ-1 (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.11	0.0009
mRNA	BRD-K55116708	CTRPv2	pan-cancer	AAC	-0.12	0.001

Download CSV